Navigation Links
Lundbeck Inc. Recognized With Award of Excellence in Corporate Achievement for Its Commitment to Huntington's Disease Community
Date:8/31/2009

DEERFIELD, Ill., Aug. 31 /PRNewswire/ -- Chicago-based Lundbeck Inc. was recently recognized with the Award of Excellence in Corporate Achievement by the Illinois Chapter of the Huntington's Disease Society of America (HDSA) for the company's significant contributions to the Huntington's disease (HD) community and making a meaningful contribution to the lives of people in the state of Illinois. The award was presented this past Friday at the fifth annual Celebration of Hope Dinner, chaired by Mayor Richard M. Daley, at the Renaissance Chicago Hotel.

"Lundbeck is committed to providing important resources and support for patients with Huntington's disease, their families and healthcare professionals in Illinois, and we're honored to receive the Award of Excellence in Corporate Achievement in recognition of our work," said Sean Nolan, Lundbeck Inc. Chief Commercial Officer. "For each and every one of us at Lundbeck, this award validates the importance of our work and signals the progress we are making towards our mission of improving the lives of people suffering from complex central nervous system disorders and rare diseases."

The Celebration of Hope gala celebrates the accomplishments of various community leaders who have made significant contributions in the areas of science, arts, philanthropy and business, as well as those who demonstrate courage and hope in the conduct of their personal and professional lives. The dinner benefits the HDSA Center of Excellence at Rush Medical Center in Chicago. The Center, one of 16 in the United States, provides people with HD and their caregivers with a variety of services to help manage their disease, including clinical care, social work, education, research, speech and occupational therapies and psychiatric care.

"When it came to selecting our corporate Award of Excellence recipient for this year, our planning committee and Board of Directors were unanimous in endorsing the nomination for Lundbeck," said Blanca Hernandez-McCarthy, Regional Manager of Special Events & Fundraising for HDSA Illinois. "We are of course thrilled that the company offers the first FDA-approved treatment for chorea associated with HD, but beyond that, we have been extremely impressed with their commitment to the many families in Illinois affected with this devastating disease through financial patient support programs and comprehensive educational programs, as well as their overall support of HDSA activities throughout the state."

About Huntington's Disease

Huntington's disease is a neurodegenerative disease that results in uncontrolled movements, emotional disturbances, and mental deterioration. HD is characterized by a combination of motor, cognitive, and psychiatric symptoms that evolve over many years.(1A,2) The average survival time after diagnosis of the illness is 15 to 20 years but can range from 10 to 30 years.(1B) Currently, there is no known cure for HD and the disease is ultimately fatal.(1C,3) For more information on HD, please visit www.hdsa.org.

About Lundbeck Inc.

Lundbeck Inc. was established in March 2009 following the acquisition of Ovation Pharmaceuticals, Inc. by Lundbeck and has proven success in developing and commercializing high-need treatments. The company is committed to providing innovative therapies that fulfill unmet medical needs of people with CNS disorders and rare diseases for which few, if any, effective treatments are available. For more information, please visit www.lundbeckinc.com.

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical company highly committed to improve the quality of life for people suffering from central nervous system (CNS) disorders. For this purpose Lundbeck is engaged in the research and development, production, marketing and sale of pharmaceuticals across the world, targeted at disorders like depression and anxiety, schizophrenia, insomnia, Huntington's, Alzheimer's and Parkinson's diseases. Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark, and employs today over 5,500 people worldwide. Lundbeck is one of the world's leading pharmaceutical companies working with CNS disorders. In 2008, the company's revenue was DKK 11.3 billion (approximately EUR 1.5 billion or USD 2.2 billion). For more information, please visit www.lundbeck.com.

    SOURCES
    1. MayoClinic.com Web site: Huntington's Disease
    Mayoclinic.com/print/huntingtonsdisease/DS00401/DSECTION=all&METHOD=print

    2. Kirkwood SC, Su JL, Conneally PM, Fouroud T. Progression of Symptoms
    in the Early and Middle Stages of Huntington Disease. Archives of
    Neurology 2001; 58: 273-278.

    3. National Institute of Neurological Disorders and Stroke Huntington's
    Disease Information Page:
    ninds.nih.gov/disorders/Huntington/Huntington.htm


'/>"/>
SOURCE Lundbeck Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigation
2. Childrens Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation
3. Twenty-Two Regional Construction Firms Recognized for Their Commitment to Worker Safety
4. Jani-King Recognized as Best in Support by the International Business Awards
5. Healthy Advice Networks Is Recognized With National Health Information Awards for Sixth Consecutive Year
6. Lifetime Commitment to Public Health Recognized
7. Sanofi-Aventis Recognized for Workplace Efforts to Prevent Cancer
8. Mobile Surgery International Assembles Team of Nationally Recognized Orthopedic Surgeons
9. CSCs FirstDoc Recognized by EMC as a Preferred Regulatory Compliance Application for Life Sciences Industry
10. Ampac Fine Chemicals LLC Recognized for Voluntarily Reducing Pollution
11. University HealthSystem Consortium Recognized as a Company That Cares for Sixth Year in a Row
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... Washington, D.C. (PRWEB) , ... May 26, 2016 , ... ... the men and women who lost their lives in military battle for the country. ... discount cards in 2015 to provide more programs that empower independence for disabled military ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, ... biologics, consumer health and global clinical supply services, today announced two key appointments ... company’s continued investment and strategic growth plans in the Asia Pacific region. , ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... chain solutions, today announced the organization has earned its ISO 13485 certification, indicating ... is compliant with all rules and policies associated with ISO quality standard 13485. ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... Orthopedics and chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., ... conference was held during May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s ...
(Date:5/26/2016)... ... May 26, 2016 , ... OncLive® , a leading ... Institute-designated University of Virginia (UVA) Cancer Center to its quickly expanding ... marketing teams will publicize and promote public awareness of UVA Cancer Center’s latest ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... CHRISTCHURCH, New Zealand , May 24, 2016 ... scanning and informatics solutions for the healthcare sector, has been ... the New Zealand Hi-Tech Awards 2016. Dr ... a fantastic acknowledgement for our team.  It,s really good to ... the burden healthcare internationally. Our products are used in 35 ...
(Date:5/24/2016)... -- The innovator of COMBO ... s first dual therapy stent, introduces catheters for lower ... a global company specializing in the provision of life-changing ... to treat peripheral artery disease. The JADE™ and Scoreflex™ ... lower limb and arteriovenous (AV) fistula intervention. ...
(Date:5/24/2016)... Dutch surgeons have launched a ground-breaking medical app to help ... on a global scale. Medical professionals from Europe ... and the US have already signed up for the app, which ... secure environment. Education  "Imagine a doctor for ... surgeon at Harvard to treat a bomb victim via live streaming ...
Breaking Medicine Technology: